Micro Emerging Active

UBS initiates coverage on Jasper Therapeutics

New narrative with limited coverage — still forming.

점수
0.4
모멘텀
▲ 0.0
기사
4
출처
1

Sentiment Timeline

Event Timeline

4월 07, 2026
Evercore ISI Lowers its Price Target on Jasper Therapeutics (JSPR) to $7 Bearish
4월 06, 2026
UBS Upgrades JFrog (FROG) to Buy with $60 Price Target on Demand … Bullish
3월 30, 2026
Edgewise Therapeutics, Inc. (EWTX) PT Increased to $45 at JPMorgan Amid Optimism … Bullish
3월 29, 2026
Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab Neutral

타임라인

최초 발견3월 29, 2026
최종 업데이트3월 29, 2026